Bausch & Lomb (BLCO) director receives 1,415 restricted share units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bausch & Lomb Corp director Steven H. Collis received a grant of restricted share units in the company. On this award date, he acquired 1,415 restricted share units, each representing a contingent right to receive one common share of Bausch & Lomb. Following this award, his directly held common share-equivalent position reported in this filing is 26,161 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
COLLIS STEVEN H
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares, No Par Value | 1,415 | $15.90 | $22K |
Holdings After Transaction:
Common Shares, No Par Value — 26,161 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Restricted share units granted: 1,415 units
Grant price reference: $15.90 per share
Holdings after award: 26,161 shares
3 metrics
Restricted share units granted
1,415 units
Equity award of common share-equivalent RSUs
Grant price reference
$15.90 per share
Reported transaction price per common share
Holdings after award
26,161 shares
Total common share-equivalents following the RSU grant
Key Terms
restricted share units, contingent right, common share, no par value
3 terms
contingent right financial
"each representing a contingent right to receive one common share"
FAQ
What insider transaction did BLCO director Steven H. Collis report?
Steven H. Collis reported receiving 1,415 restricted share units of Bausch & Lomb. These awards are compensation-related and represent contingent rights to receive common shares, rather than an open-market stock purchase or sale.
What type of security was granted to Steven H. Collis by Bausch & Lomb (BLCO)?
He received restricted share units, each representing a contingent right to one common share of Bausch & Lomb. These units typically vest over time or upon meeting conditions, rather than being immediately tradable common stock.
Was Steven H. Collis buying or selling BLCO stock in this filing?
He was not buying or selling stock on the open market. The Form 4 shows an acquisition of 1,415 restricted share units as a grant or award, which is a form of equity compensation rather than a market transaction.
Does this BLCO Form 4 indicate any derivative exercises or option trades?
The filing does not report any derivative security exercises or option transactions. It only shows a single non-derivative award of 1,415 restricted share units tied to Bausch & Lomb common shares.